Decoding the UICC 9th Edition TNM Staging in Head and Neck Cancer: Key Updates for Clinical Practice

Accurate cancer staging is fundamental to treatment planning, outcome prediction, clinical research, and policy development. The Union for International Cancer Control (UICC) 9th edition TNM classification introduces several key updates in head and neck squamous cell carcinoma (HNSCC). These include the incorporation of extranodal extension (ENE) into nodal staging for nasopharyngeal carcinoma (NPC) and HPV-associated oropharyngeal carcinoma, restructuring of stage grouping in NPC with stage IV now restricted to distant metastasis, modifications to both T and N categories in salivary gland carcinoma, and the addition of parathyroid carcinoma as a newly staged entity. These refinements aim to improve risk stratification and provide a framework for more precise and personalized treatment strategies. This review summarizes the major and minor changes and discusses their clinical implications, while emphasizing the need for further evidence to validate the prognostic utility of these recommendations.